<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0020">
 <label>Table 4</label>
 <caption>
  <p>Demographics and clinical characteristics of COVID-19 patients with diabetes in the well-controlled and poorly-controlled HbA1c groups.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Parameters</th>
    <th>HbA1c ≤ 8.6%
     <break/>(n = 43)
    </th>
    <th>HbA1c &gt; 8.6%
     <break/>(n = 21)
    </th>
    <th>P value</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Age, years</td>
    <td>64.5 (58.8–71.0)</td>
    <td>67.0 (58.5–75.0)</td>
    <td>0.535</td>
   </tr>
   <tr>
    <td>Male gender</td>
    <td>21 (48.8%)</td>
    <td>15 (71.4%)</td>
    <td>0.073</td>
   </tr>
   <tr>
    <td>Female gender</td>
    <td>22 (51.2%)</td>
    <td>6 (28.6%)</td>
    <td>
     <bold>——</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4">Comorbidities on Admission</td>
   </tr>
   <tr>
    <td>Hypertension</td>
    <td>28 (65.1%)</td>
    <td>9 (42.9%)</td>
    <td>0.090</td>
   </tr>
   <tr>
    <td>Hyperlipemia</td>
    <td>4 (9.3%)</td>
    <td>1 (4.8%)</td>
    <td>1.000</td>
   </tr>
   <tr>
    <td>Chronic renal diseases</td>
    <td>0 (0.0%)</td>
    <td>0 (0.0%)</td>
    <td>——</td>
   </tr>
   <tr>
    <td>White cell count, × 10
     <sup>9</sup>/L
    </td>
    <td>5.7 (5.0–8.0)</td>
    <td>7.7 (6.1–14.1)</td>
    <td>0.010</td>
   </tr>
   <tr>
    <td>&lt; 4</td>
    <td>5 (11.6%)</td>
    <td>1 (4.8%)</td>
    <td>0.654</td>
   </tr>
   <tr>
    <td>4–10</td>
    <td>31 (72.1%)</td>
    <td>14 (66.7%)</td>
    <td>——</td>
   </tr>
   <tr>
    <td>&gt; 10</td>
    <td>7 (16.3%)</td>
    <td>6 (28.6%)</td>
    <td>——</td>
   </tr>
   <tr>
    <td>Neutrophils, %</td>
    <td>69.1 (58.7–78.1)</td>
    <td>82.4 (67.3–88.9)</td>
    <td>0.002</td>
   </tr>
   <tr>
    <td>Lymphocyte, %</td>
    <td>20.5 (13.6–30.0)</td>
    <td>11.5 (5.9–21.8)</td>
    <td>0.011</td>
   </tr>
   <tr>
    <td>&lt; 20</td>
    <td>19 (44.2%)</td>
    <td>15 (71.4%)</td>
    <td>0.040</td>
   </tr>
   <tr>
    <td>≥20</td>
    <td>24 (55.8%)</td>
    <td>6 (28.6%)</td>
    <td>——</td>
   </tr>
   <tr>
    <td>Monocytes, %</td>
    <td>8.4 (7.2–10.3)</td>
    <td>7.1 (3.4–8.8)</td>
    <td>0.030</td>
   </tr>
   <tr>
    <td>Hemoglobin, g/L</td>
    <td>126.0 (112.0–134.0)</td>
    <td>137.0 (126.5–145.0)</td>
    <td>0.005</td>
   </tr>
   <tr>
    <td>Platelet count, × 10
     <sup>9</sup>/L
    </td>
    <td>237.0 (196.0–340.0)</td>
    <td>214.5 (166.3–312.5)</td>
    <td>0.305</td>
   </tr>
   <tr>
    <td>Alanine aminotransferase, U/L</td>
    <td>23.0 (13.0–35.0)</td>
    <td>24.0 (16.0–39.5)</td>
    <td>0.582</td>
   </tr>
   <tr>
    <td>Aspartate aminotransferase, U/L</td>
    <td>25.0 (16.0–33.0)</td>
    <td>30.0 (20.5–37.0)</td>
    <td>0.331</td>
   </tr>
   <tr>
    <td>Total bilirubin, mmol/L</td>
    <td>7.9 (5.7–10.3)</td>
    <td>8.6 (6.1–17.7)</td>
    <td>0.131</td>
   </tr>
   <tr>
    <td>Alkaline phosphatase, U/L</td>
    <td>67.0 (54.0–84.0)</td>
    <td>69.0 (58.0–85.5)</td>
    <td>0.602</td>
   </tr>
   <tr>
    <td>γ-glutamyl transferase, U/L</td>
    <td>27.0 (16.0–66.0)</td>
    <td>28.0 (19.0–65.5)</td>
    <td>0.932</td>
   </tr>
   <tr>
    <td>Total cholesterol, mmol/L</td>
    <td>3.7 (3.2–4.3)</td>
    <td>3.8 (3.1–5.0)</td>
    <td>0.516</td>
   </tr>
   <tr>
    <td>Triglyceride, mmol/L</td>
    <td>1.1 (0.9–1.7)</td>
    <td>1.8 (1.6–2.6)</td>
    <td>0.010</td>
   </tr>
   <tr>
    <td>Creatinine, μmol/L</td>
    <td>67.0 (52.0–81.0)</td>
    <td>74.0 (61.0–112.5)</td>
    <td>0.141</td>
   </tr>
   <tr>
    <td>Urea nitrogen, mmol/L</td>
    <td>5.0 (3.6–5.9)</td>
    <td>6.5 (4.5–9.7)</td>
    <td>0.016</td>
   </tr>
   <tr>
    <td>C-reactive protein, mg/L</td>
    <td>22.9 (2.0–64.4)</td>
    <td>46.9 (15.7–125.7)</td>
    <td>0.110</td>
   </tr>
   <tr>
    <td>Procalcitonin, ng/mL</td>
    <td>0.1 (0.1–0.1)</td>
    <td>0.1 (0.1–0.4)</td>
    <td>0.306</td>
   </tr>
   <tr>
    <td>Glucose, mmol/L</td>
    <td>7.6 (6.1–11.7)</td>
    <td>12.6 (8.1–19.3)</td>
    <td>0.010</td>
   </tr>
   <tr>
    <td>HbA1c, %</td>
    <td>7.3 (6.8–7.6)</td>
    <td>9.4 (9.1–10.2)</td>
    <td>&lt;0.001</td>
   </tr>
   <tr>
    <td>HbA1c, mmol/mol</td>
    <td>56 (51–60)</td>
    <td>79 (76–88)</td>
    <td>&lt;0.001</td>
   </tr>
   <tr>
    <td>Maximum of the glucose in-hospital, mmol/L</td>
    <td>8.3 (6.6–12.3)</td>
    <td>12.0 (8.8–16.5)</td>
    <td>0.002</td>
   </tr>
   <tr>
    <td>Prothrombin time, second</td>
    <td>13.4 (12.8–14.0)</td>
    <td>13.9 (13.4–15.5)</td>
    <td>0.015</td>
   </tr>
   <tr>
    <td>Activated partial thromboplastin time, second</td>
    <td>38.2 (34.3–41.9)</td>
    <td>40.3 (35.3–48.0)</td>
    <td>0.153</td>
   </tr>
   <tr>
    <td>D-dimer, mg/L</td>
    <td>0.7 (0.4–1.6)</td>
    <td>1.2 (0.6–2.2)</td>
    <td>0.217</td>
   </tr>
   <tr>
    <td>N-terminal brain natriuretic peptide precursor, pg/mL</td>
    <td>166.5 (82.0–396.8)</td>
    <td>388.5 (97.0–983.5)</td>
    <td>0.230</td>
   </tr>
   <tr>
    <td>Cardiac troponin I, ng/mL</td>
    <td>3.8 (1.9–7.6)</td>
    <td>13.8 (3.0–36.8)</td>
    <td>0.011</td>
   </tr>
   <tr>
    <td>Interleukin-6, pg/mL</td>
    <td>4.8 (1.6–27.5)</td>
    <td>12.0 (2.3–24.3)</td>
    <td>0.605</td>
   </tr>
   <tr>
    <td>Tumor necrosis factor-α, pg/mL</td>
    <td>7.3 (4.5–10.0)</td>
    <td>8.9 (6.9–10.9)</td>
    <td>0.083</td>
   </tr>
   <tr>
    <td>ICU admission</td>
    <td>0 (0.0%)</td>
    <td>11 (52.4%)</td>
    <td>&lt;0.001</td>
   </tr>
   <tr>
    <td>Immediate death</td>
    <td>0 (0.0%)</td>
    <td>1 (4.8%)</td>
    <td>0.328</td>
   </tr>
   <tr>
    <td>Worsening</td>
    <td>0 (0.0%)</td>
    <td>12 (57.1%)</td>
    <td>&lt;0.001</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="sp0070">
   <p>Abbreviations: ICU, intensive care units.</p>
  </fn>
  <fn id="sp0075">
   <p>Data are presented as numbers (%) or median [25th–75th percentile].</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
